Suchergebnisse - "Auerbach, Michael"

PubPharm (20)

1

Protocol for a multicenter, double-blinded placebo-controlled randomized controlled trial comparing intravenous ferric derisomaltose to oral ferrous sulfate for the treatment of iron deficiency anemia in pregnancy : The IVIDA2 trial

enthalten in: Contemporary clinical trials | 2022

von Lewkowitz, A. | Stout, M. | Carter, E. | +10

2

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia

enthalten in: American journal of hematology | 2021

von Auerbach, M. | Henry, D. | DeLoughery, T.

3

Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy

enthalten in: Mayo Clinic proceedings | 2021

von Auerbach, M. | Staffa, S. | Brugnara, C.

4

A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial

enthalten in: American journal of hematology | 2019

von Auerbach, M. | Henry, D. | Derman, R. | +3

5

Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron

enthalten in: American journal of hematology | 2019

von Karki, N. | Auerbach, M.

6

Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells

enthalten in: American journal of physiology. Cell physiology | 2019

von Rivera, A. | Vandorpe, D. | Shmukler, B. | +11

7

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia

enthalten in: American journal of hematology | 2018

von Derman, R. | Roman, E. | Smith-Nguyen, G. | +3

8

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia : A randomized trial

enthalten in: American journal of hematology | 2018

von Adkinson, N. | Strauss, W. | Macdougall, I. | +5

CommentIn: Am J Hematol. 2018 Sep;93(9):E231-E232. - PMID 29981266

9

A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy : The PROFOUND Trial

enthalten in: Pharmacotherapy | 2016

von Birgegård, G. | Henry, D. | Glaspy, J. | +3

10

Iron management in chronic kidney disease : conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

enthalten in: Kidney international | 2016

von Macdougall, I. | Bircher, A. | Eckardt, K. | +52